Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHavelock Europa Regulatory News (HVE)

  • There is currently no data for HVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Shareholding

7 Apr 2005 07:00

Havelock Europa PLC07 April 2005 7 April 2005 HAVELOCK EUROPA PLC Executive directors increase shareholdings Havelock Europa PLC (the "Company"), the education furniture, point of saledisplay and retail interiors group, which announced its results for the yearended 31 December 2004 yesterday, announces that it was informed on 6 April 2005that Hew Balfour, Richard Lowery and Graham MacSporran (together, the "Directors"), through a series of transactions, have increased their aggregateholding of ordinary shares in the Company from 557,521 ordinary shares (1.62% ofthe existing issued share capital) to 742,267 ordinary shares (2.14% of theenlarged issued share capital). Following the exercise of 112,143 share options, the issued share capital of theCompany is 34,630,157 ordinary shares of 10 pence each. The transactions comprise the vesting of ordinary shares under the HavelockEuropa Restricted Share Plan as a result of the Directors meeting certainperformance targets on return on capital employed in the period 1 January 2002to 31 December 2004 (see note i), the sale of ordinary shares (see note ii) andthe exercise of share options under the 1994 Executive Share Option Scheme (seenote iii). Summary of transactions The following is a summary of the Directors' transactions: Shareholding Distribution of Sale of ordinary Purchase of Shareholding before vested shares ordinary shares after transactions ordinary shares by transactions under exercise of 2002 RSP share options award Hew Balfour 270,127 107,159 107,159 80,000 350,127 (0.78%) (1.01%) Richard Lowery 88,521 81,925 25,000 32,143 177,589 (0.26%) (0.51%) Graham MacSporran 198,873 65,678 50,000 - 214,551 (0.58%) (0.62%) Total 557,521 254,762 182,159 112,143 742,267 % of issued 1.62 0.74 (0.52) 0.32 2.14share capital Note (i) Vesting of ordinary shares under the Havelock Europa Restricted Share Plan ("RSP") In accordance with the rules of the RSP, the award dated 9 January 2002 vested 431,801 ordinary shares (1.25% of the existing issued share capital) to the Directors. The vesting of ordinary shares was the result of the Directors meeting certain performance targets on return on capital employed in the period 1 January 2002 to 31 December 2004. The Trustees of the RSP subsequently sold 177,038 ordinary shares (0.51% of the existing issued share capital) at 120 pence per ordinary share, on behalf of the Directors, to meet the PAYE and NI liabilities due on vesting of these ordinary shares, as follows: Hew Balfour 74,467 ordinary shares (0.22%) Richard Lowery 56,931 ordinary shares (0.16%) Graham MacSporran 45,641 ordinary shares (0.13%) The balance of 254,763 ordinary shares (0.74% of the existing issued share capital) was distributed to the Directors as follows: Hew Balfour 107,159 ordinary shares (0.31%) Richard Lowery 81,925 ordinary shares (0.24%) Graham MacSporran 65,678 ordinary shares (0.19%) Note (ii) Directors' sale of ordinary shares On 5 April 2005, the Directors sold 182,159 ordinary shares (0.52% of the existing issued share capital) at 120 pence per ordinary share as follows: Hew Balfour 107,159 ordinary shares (0.31%) Richard Lowery 25,000 ordinary shares (0.07%) Graham MacSporran 50,000 ordinary shares (0.14%) Note (iii) Directors' exercise of executive share options On 6 April 2005, Hew Balfour and Richard Lowery purchased a total of 112,143 ordinary shares by exercising the following executive share options: Hew Balfour 80,000 share options at an exercise price of 37.0 pence per option. Option granted October 1999 Richard Lowery 25,000 share options at an exercise price of 105.0 pence per option. Option granted May 1998 7,143 share options at an exercise price of 52.5 pence per option. Option granted April 1999 Enquiries: Havelock Europa PLC 01383-820 044Hew Balfour (Chief Executive) 07801-683 851Graham MacSporran (Finance Director) 07801-683 803 Teather & Greenwood LimitedTom Hulme (Corporate Broking) 020-7426 9593 Bankside Consultants LimitedCharles Ponsonby 020-7444 4166 - END - This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jul 201811:41 amRNSAppointment of Administrators & Nomad Resignation
29th Jun 20182:50 pmRNSResults of Annual General Meeting
29th Jun 20187:23 amRNSNotice of intention to appoint Administrators
27th Jun 20187:30 amRNSSuspension - Havelock Europa Plc
27th Jun 20187:30 amRNSFinance Update
31st May 20185:20 pmRNSAnnual Report and Accounts and notification of AGM
31st May 20183:46 pmRNS2017 Final Results
3rd May 201811:10 amRNSNotice of Results
1st May 201810:23 amRNSAppointment of Non-Executive Director
29th Mar 20184:10 pmRNSNotice of Results
6th Mar 20187:00 amRNSDirectorate Change
2nd Mar 20181:01 pmRNSFunding update
21st Feb 201812:42 pmRNSHolding(s) in Company
20th Feb 20187:00 amRNSCorporate Update
31st Oct 20178:49 amRNSStrategy Update
11th Oct 20175:57 pmRNSHolding(s) in Company
3rd Oct 20173:02 pmRNSHolding(s) in Company
27th Sep 20177:01 amRNSInterim results
27th Sep 20177:00 amRNSDirectorate Change
22nd Sep 20177:00 amRNSNotification of Major Interest in Shares
7th Sep 20177:00 amRNSTrading Statement
13th Jun 201712:51 pmRNSAGM Statement
13th Jun 201712:00 pmRNSAGM Statement
25th Apr 20177:00 amRNSFinal Results and New Financing Arrangements
10th Apr 201711:54 amRNSHolding(s) in Company
31st Mar 20177:00 amRNSAppointment of new Chief Financial Officer
20th Mar 20177:25 amRNSHolding(s) in Company
13th Mar 20173:25 pmRNSHolding(s) in Company
28th Feb 201711:12 amRNSFinal Results Pre-announcement
8th Feb 20172:57 pmRNSBlock Listing Six Monthly Return
1st Feb 20172:27 pmRNSHolding(s) in Company
25th Jan 201711:37 amRNSIssue of Equity
25th Jan 201710:56 amRNSNotification of Interests
25th Jan 201710:48 amRNSTrading Statement
20th Dec 20167:00 amRNSNew Chairman and proposed issue of new shares
22nd Sep 20167:00 amRNSHavelock Europa PLC Interim Results
14th Jul 20165:31 pmRNSBlocklisting Interim Review
14th Jun 20167:00 amRNSNotification of Interests - Andrew Burgess
10th Jun 20163:08 pmRNSResult of AGM
10th Jun 201612:00 pmRNSAGM Statement and Directorate Change
26th May 20167:00 amRNSHavelock Europa Annual Financial Report & Accounts
5th May 20167:00 amRNSDirector Shareholding
29th Apr 20167:00 amRNSHavelock Europa - Appointment of Non-Exec Director
14th Apr 20167:00 amRNSHavelock Europa Final Results
12th Feb 201610:15 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSHavelock Europa PLC Trading Statement
18th Dec 20157:00 amRNSHAVELOCK EUROPA APPOINTS NOMINATED ADVISER
16th Dec 20152:57 pmRNSDirectorate Change
24th Nov 20155:39 pmRNSDirector/PDMR Shareholding
17th Nov 20158:52 amRNSReplacement: Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.